These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3613256)

  • 1. Clinico-pathological study of atypical membranoproliferative glomerulonephritis.
    Yoshida Y; Taguchi H; Yogi S; Nagasaka Y; Shimoyama K; Fujiwara Y
    Nihon Jinzo Gakkai Shi; 1987 Mar; 29(3):283-91. PubMed ID: 3613256
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic significance of some clinical and histological parameters in membranoproliferative glomerulonephritis (GNMP). Study of 112 cases].
    Belgiojoso GB; Tarantino A; Golasanti G; Bazzi C; Guerra L; Durante A
    Minerva Nefrol; 1976; 23(4):260-70. PubMed ID: 1024166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-pathological study of idiopathic membranous glomerulonephritis].
    Amagasaki Y
    Nihon Jinzo Gakkai Shi; 1985 Jan; 27(1):123-37. PubMed ID: 4010059
    [No Abstract]   [Full Text] [Related]  

  • 4. Dense deposit disease: a variant of membranoproliferative glomerulonephritis.
    Habib R; Gubler MC; Loirat C; Mäiz HB; Levy M
    Kidney Int; 1975 Apr; 7(4):204-15. PubMed ID: 1095806
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of mixed membranous and proliferative glomerulonephritis: recognition of three varieties.
    Burkholder PM; Hyman LR; Krueger RP
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():557-89. PubMed ID: 4620927
    [No Abstract]   [Full Text] [Related]  

  • 6. Lobular glomerulonephritis and membranoproliferative glomerulonephritis: a clinical and pathologic study based on renal biopsies.
    Mandalenakis N; Mendoza N; Pirani CL; Pollak VE
    Medicine (Baltimore); 1971 Jul; 50(4):319-55. PubMed ID: 5143573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-morphologic characteristics of experimental autoimmune glomerulonephritis during the use of prednisolone].
    Bykovskaia KN
    Arkh Patol; 1969; 31(6):32-7. PubMed ID: 5358924
    [No Abstract]   [Full Text] [Related]  

  • 8. [Membranoproliferative glomerulonephritis. Clinico-pathological and therapeutic correlations].
    Urízar R; Cerda J
    Rev Chil Pediatr; 1986; 57(2):201-13. PubMed ID: 3550928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of renal histological findings, serum C3, C4 level in patients with lupus nephritis by steroid therapy].
    Sueishi M; Tomioka H; Yanagisawa T; Nawata Y; Kagami M; Koike T; Takabayashi K; Yoshida S; Kumagai A; Tsuchida H
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):343-52. PubMed ID: 6471579
    [No Abstract]   [Full Text] [Related]  

  • 10. A case report of membranoproliferative glomerulonephritis type II with atypical intramembranous dense deposits.
    Fukushi K; Yamabe H; Sugawara N; Ozawa K; Kubota H; Hanada S; Osawa H; Onodera K; Kimura M; Kurita S
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):287-93. PubMed ID: 4021192
    [No Abstract]   [Full Text] [Related]  

  • 11. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF; McEnery PT; McAdams AJ; West CD
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
    Mampaso F; Leyva-Cobián F; Martínez-Montero JC; Gonzalo A; Bellas C; Moneo I; Junquera E
    Clin Nephrol; 1983 Feb; 19(2):92-8. PubMed ID: 6188567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proliferative mesangial glomerulonephritis. Clinico-pathological study of 23 cases].
    Sánchez J; Rivero Sánchez LM; Picazo ML; Almaraz Jiménez MA; Miguel Alonso JL; Martinez Ara J; Torre Carballada MA; Montero García A; Sánchez Sicilia L
    Rev Clin Esp; 1976 Feb; 140(3):257-68. PubMed ID: 1257529
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune deposits in generalised mesangioproliferative glomerulonephritis. Fluorescent microscopy findings correlated to symptoms, clinical course and immunosuppressive therapy.
    Larsen S
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):543-52. PubMed ID: 362810
    [No Abstract]   [Full Text] [Related]  

  • 15. [The pathology of glomerulonephritis].
    Thoenes W
    Internist (Berl); 1989 Mar; 30(3):127-39. PubMed ID: 2654057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunopathology of the kidney in disseminated lupus erythematosus].
    Morel-Maroger L; Méry JP
    Pathol Biol (Paris); 1975 Jun; 23(6):492-3. PubMed ID: 1105354
    [No Abstract]   [Full Text] [Related]  

  • 17. Dense deposit disease: its possible pathogenesis suggested by an observation of a patient.
    Sato H; Saito T; Seino J; Ootaka T; Kyogoku Y; Furuyama T; Yoshinaga K
    Clin Nephrol; 1987 Jan; 27(1):41-5. PubMed ID: 3545573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of prednisolone on the course of experimental glomerulonephritis].
    Bykovskaia KN; Vikhert AM; Glezer GA
    Arkh Patol; 1966; 28(4):25-31. PubMed ID: 6000324
    [No Abstract]   [Full Text] [Related]  

  • 19. Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases.
    Habib R; Kleinknecht C; Gubler MC; Levy M
    Clin Nephrol; 1973; 1(4):194-214. PubMed ID: 4131568
    [No Abstract]   [Full Text] [Related]  

  • 20. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.